Skip to main content
Erschienen in: CardioVascular and Interventional Radiology 8/2017

26.05.2017 | Letter to the Editor

Safety and Efficacy of Y-90 Radioembolization After Prior Major Hepatic Resection: Dosimetric Consideration

verfasst von: Morsal Samim, Marnix G. E. H. Lam

Erschienen in: CardioVascular and Interventional Radiology | Ausgabe 8/2017

Einloggen, um Zugang zu erhalten

Excerpt

With great interest, we read the article by Zimmermann et al., addressing the safety of radioembolization with yttrium-90 resin microspheres (90Y RE) in patients with a history of major hepatic resection [1]. In all patients, the body surface area (BSA) method was used for activity calculation. The authors concluded that 90Y RE was safe in patients with a history of major liver resection (including extended hemihepatectomy) while using the BSA method for activity calculation. This study addresses a clinically important issue that needs attention. There are no guidelines on activity adjustments in patients with a heavily pretreated liver (either surgery or systemic treatment). Clinical studies investigating this issue are clearly needed. However, the results of the presented study should be evaluated critically, before assumptions become guidelines. …
Literatur
1.
Zurück zum Zitat Zimmermann M, Schulze-Hagen M, Liebl M, et al. Safety and efficacy of Y-90 radioembolization after prior major hepatic resection. Cardiovasc Intervent Radiol. 2017. doi:10.1007/s00270-017-1629-x. Zimmermann M, Schulze-Hagen M, Liebl M, et al. Safety and efficacy of Y-90 radioembolization after prior major hepatic resection. Cardiovasc Intervent Radiol. 2017. doi:10.​1007/​s00270-017-1629-x.
2.
Zurück zum Zitat Guglielmi A, Ruzzenente A, Conci S, et al. How much remnant is enough in liver resection? Dig Surg. 2012;29:6–17.CrossRefPubMed Guglielmi A, Ruzzenente A, Conci S, et al. How much remnant is enough in liver resection? Dig Surg. 2012;29:6–17.CrossRefPubMed
3.
Zurück zum Zitat Gil-Alzugaray B, Chopitea A, Inarrairaegui M, et al. Prognostic factors and prevention of radioembolization-induced liver disease. Hepatology. 2013;57:1078–87.CrossRefPubMed Gil-Alzugaray B, Chopitea A, Inarrairaegui M, et al. Prognostic factors and prevention of radioembolization-induced liver disease. Hepatology. 2013;57:1078–87.CrossRefPubMed
4.
Zurück zum Zitat Lau WY, Kennedy AS, Kim YH, et al. Patient selection and activity planning guide for selective internal radiotherapy with yttrium-90 resin microspheres. Int J Radiat Oncol Biol Phys. 2012;82:401–7.CrossRefPubMed Lau WY, Kennedy AS, Kim YH, et al. Patient selection and activity planning guide for selective internal radiotherapy with yttrium-90 resin microspheres. Int J Radiat Oncol Biol Phys. 2012;82:401–7.CrossRefPubMed
5.
Zurück zum Zitat Tong AK, Kao YH, Too CW, et al. Yttrium-90 hepatic radioembolization: clinical review and current techniques in interventional radiology and personalized dosimetry. Br J Radiol. 2016;89:20150943.CrossRefPubMedPubMedCentral Tong AK, Kao YH, Too CW, et al. Yttrium-90 hepatic radioembolization: clinical review and current techniques in interventional radiology and personalized dosimetry. Br J Radiol. 2016;89:20150943.CrossRefPubMedPubMedCentral
Metadaten
Titel
Safety and Efficacy of Y-90 Radioembolization After Prior Major Hepatic Resection: Dosimetric Consideration
verfasst von
Morsal Samim
Marnix G. E. H. Lam
Publikationsdatum
26.05.2017
Verlag
Springer US
Erschienen in
CardioVascular and Interventional Radiology / Ausgabe 8/2017
Print ISSN: 0174-1551
Elektronische ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-017-1704-3

Weitere Artikel der Ausgabe 8/2017

CardioVascular and Interventional Radiology 8/2017 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.